Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Clinical Immunology (Orlando, Fla.)|February 5, 2024
Border-associated macrophages in the central nervous systemRui Sun, Haowu JiangJournal of Neuroinflammation|March 14, 2024
Border-associated macrophages in the central nervous systemRui Sun, Haowu JiangJournal of Experimental & Clinical Cancer Research : CR|June 30, 2026
Decoding glioblastoma evolution and heterogeneity through mechanistic modeling: implications for clinical translationHaowu Jiang, Wan Zhao, Hui Zhou, et al.Brain, Behavior, and Immunity|March 7, 2017
Nociceptive neuronal Fc-gamma receptor I is involved in IgG immune complex induced pain in the ratHaowu Jiang, Xinhua Shen, Zhiyong Chen, et al.Oncotarget|April 21, 2017
Inhibition activity of a disulfide-stabilized diabody against basic fibroblast growth factor in lung cancerYaxiong Cai, Shuange Yao, Jiangchuan Zhong, et al.Cancer Gene Therapy|April 15, 2021
Targeting KDM1B-dependent miR-215-AR-AGR2-axis promotes sensitivity to enzalutamide-resistant prostate cancerDonge Tang, Jiaxi He, Yong Dai, et al.Nature Communications|December 14, 2019
TRPV1 activity and substance P release are required for corneal cold nociceptionFengxian Li, Weishan Yang, Haowu Jiang, et al.The Journal of Investigative Dermatology|September 27, 2021
TRPC3 Antagonizes Pruritus in a Mouse Contact Dermatitis ModelKatherine Beattie, Haowu Jiang, Mayank Gautam, et al.Brain, Behavior, and Immunity|April 15, 2019
CCL2/CCR2 signaling elicits itch- and pain-like behavior in a murine model of allergic contact dermatitisHaowu Jiang, Huan Cui, Tao Wang, et al.Cancer Science|June 3, 2016
Construction of a disulfide-stabilized diabody against fibroblast growth factor-2 and the inhibition activity in targeting breast cancerYaxiong Cai, Jinxia Zhang, Xuejun Lao, et al.Pageof 2